BioSpace News Archive

Evolve Biologics Inc. (“Evolve”), an innovative plasma-derived therapeutics company, today announced its selection of DPR Construction to act as the General Contractor for construction of its new state-of-the-art commercial facility to be built in one of several recently shortlisted locations in Texas.

Humanigen, Inc. today announced that they have entered into a manufacturing services agreement to produce lenzilumab bulk drug substance and drug product for Humanigen for commercial sale following receipt of the requisite regulatory authorizations or approvals in regions outside of the United States including Europe, the United Kingdom, India and Brazil.

Petros Pharmaceuticals, Inc. (Petros or the Company) (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today announced financial results for the first quarter ended March 31, 2021

Biotech industry veteran brings over 20 years of project and alliance management experience largely focused on oncology and clinical development

DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical Company focused on developing novel treatments for neurological disorders and kidney diseases, announced today that the U.S. Food & Drug Administration (FDA) has accepted the Company’s Investigational New Drug (IND) application.

Avail Dermatology, an acclaimed dermatological provider for more than 30 years, expands its practice by opening a new location in Fayetteville.

Professor Akimichi Morita, Vice Director of Nagoya City University Hospital, will lead RepliCel’s Skin Rejuvenation Clinical Testing in Japan

Accelerating Discovery by Providing High Throughput Spatial Analysis of any RNA Target in the Primary Model Organism for Discovery

ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the health and wellness market in China, announced today that on May 10, 2021, a new product, Puxue Oral Liquid, which is a supplement intended for use by children aged between one and 17, adults, pregnant women, and nursing mothers who suffer from iron and vitamin B12 deficiencies, is jointly launched by the Company and Harbin Pharmaceutical

OraSure Technologies, Inc., a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, announced that Scott Gleason has been appointed Senior Vice President Investor Relations and Corporate Communications.